Results 41 to 50 of about 56,989 (154)
Are local guidelines on investigations in children admitted with acute gastroenteritis being adhered to? [PDF]
, 2015 The aim of this article is to assess adherence to local guidelines on the investigation of children admitted with acute gastroenteritis. Children admitted to Mater Dei Hospital with a diagnosis of gastroenteritis between December 2012 and February 2013 ...
Agius, Marija +3 more
core
Multifaceted Roles of Chloroquines in Gastrointestinal Disorders and Beyond
Comprehensive Physiology, Volume 16, Issue 4, August 2026.Chloroquine (CQ) and hydroxychloroquine (HCQ) modulate lysosomal activity and autophagy, suppressing gastrointestinal inflammation and reshaping pathogenic microbiota. These mechanisms alleviate inflammatory bowel disease, inhibit associated tumor growth, and provide benefits in certain autoimmune and viral conditions.
Sihyun Jeong +3 more
wiley +1 more source
A case report on the long‐term use of teduglutide in a pediatric patient with short bowel syndrome
Nutrition in Clinical Practice, Volume 41, Issue 4, Page 1253-1259, August 2026.Abstract Short bowel syndrome (SBS) is the leading cause of intestinal failure, frequently necessitating long‐term parenteral nutrition (PN). Teduglutide (TED), a glucagon‐like peptide‐2 analog, has demonstrated efficacy in reducing PN dependence in both adults and children. However, long‐term data in pediatric populations remain limited.
Tsuyoshi Sakurai +8 more
wiley +1 more source
Malignant tumor masquerading as eosinophilic gastroenteritis.
, 1987 A 49-year-old patient presented with urticaria, vomiting, diarrhea and peripheral eosinophilia. A histological diagnosis of eosinophilic gastroenteritis was made.
Reshef, R +4 more
core +1 more source
Eosinophilic ascites: A case report and literature review
Journal of Family and Community Medicine, 2015 Eosinophilic gastroenteritis is a rare gastrointestinal (GI) disorder characterized by nonspecific GI symptoms, peripheral eosinophilia, and eosinophilic infiltration of the intestinal wall.
Raed M Alsulaiman
doaj +1 more source
Microbial Biotechnology, Volume 19, Issue 8, August 2026.This study evaluated the 3‐month safety and tolerability of the probiotic CP‐9 in healthy infants aged 6 to 36 months. The research confirmed that, under the conditions of this study, CP‐9 can safely enrich specific beneficial bacterium in the gut without any obvious short‐term safety signal. ABSTRACT Infancy represents a critical period for growth and
Liujing Zhang +15 more
wiley +1 more source
A Case Report of Eosinophilic Gastroenteritis Presenting with Abdominal Pain and Ascitis
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2009 Background and Objectives: Eosinophilic gastroenteritis is a heterogeneous disorder affecting both children and adults, and is characterized by the presence of an intense eosinophilic infiltrate on histopathology of one or multiple segments from the ...
MR Ghadir, AM Ghanooni, N Khanahmadi
doaj
Eosinophilic Gastroenteritis: Review of a Rare and Treatable Disease of the Gastrointestinal Tract
Case Reports in Gastroenterology, 2013 Eosinophilic gastroenteritis is a rare disease of the gastrointestinal tract characterized by crampy abdominal pain, nausea, vomiting, diarrhea, gastrointestinal bleeding, and weight loss associated with peripheral eosinophilia leading to eosinophilic ...
Amit Mori +3 more
doaj +1 more source
Postbiotics: An Overview and Recommendations for Improved Reporting
Molecular Nutrition &Food Research, Volume 70, Issue 14, 29 July 2026.Human clinical trials of postbiotics and corresponding preclinical evidence were evaluated. Key reporting gaps identified included inconsistent terminology, incomplete inactivation method reporting, variable dosing information, insufficient quality‐control data, and inadequate taxonomic characterization.
Mehreen Anjum, Arthur C. Ouwehand
wiley +1 more source
Gastrointestinal manifestations during oral immunotherapy: A guide for pediatric allergists
Pediatric Allergy and Immunology, Volume 37, Issue 7, July 2026.Gastrointestinal manifestations occurring during oral immunotherapy (OIT) encompass a spectrum of conditions ranging from immediate IgE‐mediated reactions to delayed eosinophil‐associated disorders, including eosinophilic esophagitis. Because symptoms may overlap with other gastrointestinal diseases, a structured assessment based on symptom timing ...
Martina Votto +11 more
wiley +1 more source